BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4858237)

  • 1. Persistence of antibody to envelope antigens of Heq2Neq2 virus in ponies after infection and vaccination.
    Cameron TP; Kasel JA; Couch RB
    Proc Soc Exp Biol Med; 1974 Jul; 146(3):658-60. PubMed ID: 4858237
    [No Abstract]   [Full Text] [Related]  

  • 2. Surveillance for immunity against equine influenza virus infections.
    Bürki F; Lamatsch O
    Comp Immunol Microbiol Infect Dis; 1981; 4(3-4):267-78. PubMed ID: 6174266
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution to the antigenic study of influenza viruses in animals. II.--Antibodies, antineuraminidase in horse: conditions of apparition and importance (author's transl)].
    Fontaine M; Fontaine M
    Ann Rech Vet; 1975; 6(4):411-20. PubMed ID: 1231622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of influenza vaccine potency by means of a standardized hemagglutination inhibition test.
    Bürki F; Sibalin M
    Dev Biol Stand; 1974; 26():42-8. PubMed ID: 4435307
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene.
    Lunn DP; Soboll G; Schram BR; Quass J; McGregor MW; Drape RJ; Macklin MD; McCabe DE; Swain WF; Olsen CW
    Vaccine; 1999 May; 17(18):2245-58. PubMed ID: 10403592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigens (and recombinants) and immune response to avian influenza.
    Easterday BC
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):503-4. PubMed ID: 1092217
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic variation of equine (Heq2Neq2) influenzavirus.
    Pereira HG; Takimoto S; Piegas NS; do Valle LA
    Bull World Health Organ; 1972; 47(4):465-9. PubMed ID: 4540996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
    Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response.
    Soboll G; Nelson KM; Leuthner ES; Clark RJ; Drape R; Macklin MD; Swain WF; Olsen CW; Lunn DP
    Vaccine; 2003 Jun; 21(21-22):3081-92. PubMed ID: 12798652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
    Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
    Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
    Mumford J; Wood JM; Scott AM; Folkers C; Schild GC
    J Hyg (Lond); 1983 Jun; 90(3):385-95. PubMed ID: 6306098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza titers among racehorses.
    Martin RJ; Schnurrenberger PR; McQueen JL; Meerdink GL
    Mod Vet Pract; 1972 May; 53(5):45-6. PubMed ID: 5030015
    [No Abstract]   [Full Text] [Related]  

  • 13. Simultaneous occurrence of A-equi-1 and A-equi-2 infleunza viruses in a small group of horses.
    Tumova B; Easterday BC; Stumpa A
    Am J Epidemiol; 1972 Jan; 95(1):80-7. PubMed ID: 5061699
    [No Abstract]   [Full Text] [Related]  

  • 14. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination.
    Nelson KM; Schram BR; McGregor MW; Sheoran AS; Olsen CW; Lunn DP
    Vaccine; 1998 Aug; 16(13):1306-13. PubMed ID: 9682395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination and protection experiments in mice with the human A-1957 and A-1968 strains, and the Equi-2 strain of influenza virus.
    Masurel N; Baars AJ; Frankena H
    Antonie Van Leeuwenhoek; 1973; 39(3):461-71. PubMed ID: 4543055
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression.
    Lunn DP; Hussey S; Sebing R; Rushlow KE; Radecki SV; Whitaker-Dowling P; Youngner JS; Chambers TM; Holland RE; Horohov DW
    J Am Vet Med Assoc; 2001 Mar; 218(6):900-6. PubMed ID: 11294315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field and laboratory studies of equine influenza viruses isolated in 1979.
    Burrows R; Denyer M; Goodridge D; Hamilton F
    Vet Rec; 1981 Oct; 109(16):353-6. PubMed ID: 6275599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serologic survey on equine influenza for the past ten years.
    Goto H; Shinagawa M; Shimizu K; Taya Y; Noda H; Tokunaga T
    Nihon Juigaku Zasshi; 1978 Aug; 40(4):367-74. PubMed ID: 212632
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistence in nature of influenza virus A/eq/Praha/56 (Heq1Neq1).
    Tåmová B; Stumpa A; Zakopal J; Vĕzníková D; Mensík J
    Acta Virol; 1980 Jan; 24(1):63-7. PubMed ID: 6104433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.